Hematopoietic stem cell transduction and amplification in large animal models

Human Gene Therapy

Volumn 16, Issue 12, 2005, Pages 1355-1366

  Trobridge, Grant ^a,b   Beard, Brian C ^a   Kiem, Hans Peter ^a,b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 O BENZYLGUANINE; CARMUSTINE; DIHYDROFOLATE REDUCTASE; FK 506 BINDING PROTEIN; FLT3 LIGAND; G GLYCOPROTEIN; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE COLONY STIMULATING FACTOR RECEPTOR; GREEN FLUORESCENT PROTEIN; HOMEODOMAIN PROTEIN; INTERLEUKIN 3; INTERLEUKIN 6; LENTIVIRUS VECTOR; MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; MULTIDRUG RESISTANCE PROTEIN 1; PACLITAXEL; PROTEIN HOXB4; PROTEIN HOXB4 TRANSACTIVATOR FUSION PROTEIN; RETROVIRUS VECTOR; STEM CELL FACTOR; STEROID; TACROLIMUS; TAMOXIFEN; TEMOZOLOMIDE; THROMBOPOIETIN; THROMBOPOIETIN RECEPTOR; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN;

ANIMAL MODEL; BONE MARROW SUPPRESSION; CELL BASED GENE THERAPY; CELL POPULATION; CELL SELECTION; CYTOTOXICITY; ENVELOPE PSEUDOTYPE VECTOR; FLOW CYTOMETRY; GENE AMPLIFICATION; GENE LOCUS; GENE TRANSFER; GENE VECTOR; GENETIC DISORDER; GENETIC TRANSDUCTION; HEMATOPOIETIC STEM CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VIVO STUDY; INFECTION; LUNG TOXICITY; MARKER GENE; MUTAGENESIS; MYELOABLATIVE CONDITIONING; NONHUMAN; PROTEIN EXPRESSION; REVIEW; SPUMA VIRUS; TOXICITY TESTING; TRANSGENE; ULTRACENTRIFUGATION; VIRUS ENVELOPE;

ANIMALS; DOGS; GENE AMPLIFICATION; GENE THERAPY; HEMATOPOIETIC STEM CELLS; MODELS, ANIMAL; O(6)-METHYLGUANINE-DNA METHYLTRANSFERASE; PRIMATES; SEVERE COMBINED IMMUNODEFICIENCY; STEM CELL TRANSPLANTATION; TRANSDUCTION, GENETIC;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS 1; LENTIVIRUS; MURINAE; PRIMATES; SPUMAVIRUS;

EID: 29244441185     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2005.16.1355     Document Type: Review

References (118)

1. AILLES, L., SCHMIDT, M., SANTONI, D.S.F., GLIMM, H., CAVALIERI, S., BRUNO, S., PIACIBELLO, W., VON KALLE, C., and NALDINI, L. (2002). Molecular evidence of lentiviral vector-mediated gene transfer into human self-renewing, multi-potent, long-term NOD/SCID repopulating hematopoietic cells. Mol. Ther. 6, 615-626.
2. + cells with a human immunodeficiency virus type 1-based retroviral vector pseudotyped with vesicular stomatitis virus envelope glycoprotein G. J. Virol. 70, 2581-2585.
3. ALLAY, J.A., PERSONS, D.A., GALIPEAU, J., RIBERDY, J.M., ASHMUN, R.A., BLAKLEY, R.L., and SORRENTINO, B.P. (1998). In vivo selection of retrovirally transduced hematopoietic stem cells. Nat. Med. 4, 1136-1143.
4. + cells. J. Virol. 74, 1286-1295.
5. AN, D.S., KUNG, S.K., BONIFACINO, A., WERSTO, R.P., METZGER, M.E., AGRICOLA, B.A., MAO, S.H., CHEN, I.S., and DONAHUE, R.E. (2001). Lentivirus vector-mediated hematopoietic stem cell gene transfer of common γ-chain cytokine receptor in rhesus macaques. J. Virol. 75, 3547-3555.
6. + bone marrow cells. Blood 82, 1975-1980.
7. BRENNER, M.K., RILL, D.R., HOLLADAY, M.S., HESLOP, H.E., MOEN, R.C., BUSCHLE, M., KRANCE, R.A., SANTANA, V.M., ANDERSON, W.F., and IHLE, J.N. (1993). Gene marking to determine whether autologous marrow infusion restores long-term haemopoiesis in cancer patients. Lancet 342, 1134-1137.
8. + cells. Blood 102, 2789-2797.
9. BURNS, J.C., FRIEDMANN, T., DRIEVER, W., BURRASCANO, M., and YEE, J.K. (1993). Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: Concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. Proc. Natl. Acad. Sci. U.S.A. 90, 8033-8037.
10. CALMELS, B., FERGUSON, C., LAUKKANEN, M.O., ADLER, R., FAULHABER, M., HYEOUNG-JOON, K., SELLERS, S., HEMATTI, P., SCHMIDT, M., VON KALLE, C., AKAGI, K., DONAHUE, R.E., and DUNBAR, C.E. (2005). Recurrent retroviral vector integration at the MDS1-EVI1 locus in non-human primate hematopoietic cells. Blood 106, 2530-2533.
11. -human hematopoietic cells by HIV-1-based lentiviral vectors. Proc. Natl. Acad. Sci. U.S.A. 96, 2988-2993.
12. CHAO, N.J., EMERSON, S.G., and WEINBERG, K.I. (2004). Stem cell transplantation (cord blood transplants) [review]. Hematology (Am. Soc. Hematol. Educ. Program). 354-371.
13. CONE, R.D., and MULLIGAN, R.C. (1984). High-efficiency gene transfer into mammalian cells: Generation of helper-free recombinant retrovirus with broad mammalian host range. Proc. Natl. Acad. Sci. U.S.A. 81, 6349-6353.
14. 6-benzylguanine. Cancer Res. 54, 6221-6227.
15. DAO, M.A., HASHINGO, K., KATO, I., and NOLTA, J.A. (1998). Adhesion to fibronectin maintains regenerative capacity during ex vivo culture and transduction of human hematopoietic stem and progenitor cells. Blood 92, 4612-4621.
16. V mice. Cell 42, 71-79.
17. + cells. Blood 95, 445-452.
18. + cells. Mol. Ther. 3, 359-367.
19. DUNBAR, C.E., COTTLER-FOX, M., O'SHAUGHNESSY, J.A., DOREN, S., CARTER, C., BERENSON, R., BROWN, S., MOEN, R.C., GREENBLATT, J., STEWART, P.M., LEITMAN, S.F., WILSON, W.H., COWAN, K., YOUNG, N.S., and NIENHUIS, A.W. (1995). Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantation. Blood 85, 3048-3057.
20. DUNBAR, C.E., SEIDEL, N.E., DOREN, S., SELLERS, S., CLINE, A.P., METZGER, M.E., AGRICOLA, B.A., DONAHUE, R.E., and BODINE, D.M. (1996). Improved retroviral gene transfer into murine and rhesus peripheral blood or bone marrow repopulating cells primed in vivo with stem cell factor and granulocyte colony-stimulating factor. Proc. Natl. Acad. Sci. U.S.A. 93, 11871-11876.
21. EMI, N., FRIEDMANN, T., and YEE, J.K. (1991). Pseudotype formation of murine leukemia virus with the G protein of vesicular stomatitis virus. J. Virol. 65, 1202-1207.
22. GOERNER, M., BRUNO, B., McSWEENEY, P.A., BURON, G., STORB, R., and KIEM, H.-P. (1999). The use of granulocyte colony-stimulating factor during retroviral transduction on fibronectin fragment CH-296 enhances gene transfer into hematopoietic repopulating cells in dogs. Blood 94, 2287-2292.
23. + marrow cells transduced by RD114-pseudotype oncoretrovirus vectors. Blood 98, 2065-2070.
24. GREEN, B.J., LEE, C.S., and RASKO, J.E. (2004). Biodistribution of the RD114/mammalian type D retrovirus receptor, RDR. J. Gene Med. 6, 249-259.
25. GREINER, D.L., HESSELTON, R.A., and SHULTZ, L.D. (1998). SCID mouse models of human stem cell engraftment [review]. Stem Cells 16, 166-177.
26. GUENECHEA, G., GAN, O.I., DORRELL, C., and DICK, J.E. (2001). Distinct classes of human stem cells that differ in proliferative and self-renewal potential. Nat. Immunol. 2, 75-82.
27. HACEIN-BEY-ABINA, S., VON KALLE, C., SCHMIDT, M., LE DEIST, F. , WULFFRAAT, N., McINTYRE, E., RADFORD, I., VILLEVAL, J.L., FRASER, C.C., CAVAZZANA-CALVO, M., and FISCHER, A. (2003). A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N. Engl. J. Med. 348, 255-256.
28. HAHN, W.C., and WEINBERG, R.A. (2002). Rules for making human tumor cells [review]. [Erratum appears in N. Engl. J. Med. 2003;348:674.]. N. Engl. J. Med. 347, 1593-1603.
29. HAHN, W.C., COUNTER, C.M., LUNDBERG, A.S., BEIJERSBERGEN, R.L., BROOKS, M.W., and WEINBERG, R.A. (1999). Creation of human tumour cells with defined genetic elements. Nature 400, 464-468.
30. HALENE, S., WANG, L., COOPER, R.M., BOCKSTOCE, D.C., ROBBINS, P.B., and KOHN, D.B. (1999). Improved expression in hematopoietic and lymphoid cells in mice after transplantation of bone marrow transduced with a modified retroviral vector. Blood 94, 3349-3357.
31. HANAZONO, Y., NAGASHIMA, T., TAKATOKU, M., SHIBATA, H., AGEYAMA, N., ASANO, T., UEDA, Y., DUNBAR, C.E., KUME, A., TERAO, K., HASEGAWA, M., and OZAWA, K. (2002). In vivo selective expansion of gene-modified hematopoietic cells in a nonhuman primate model. Gene Then 9, 1055-1064.
32. HANENBERG, H., XIAO, X.L., DILLOO, D., HASHING, K., KATO, I., and WILLIAMS, D.A. (1996). Colocalization of retrovirus and target cells on specific fibronectin fragments increases genetic transduction of mammalian cells. Nat. Med. 2, 876-882.
33. HARRISON, D.E. (1980). Competitive repopulation: A new assay for long-term stem cell functional capacity. Blood 55, 77-81.
34. + cells is superior to G-CSF or G-CSF+Flt3-L-mobilized cells in non-human primates. Blood 101, 2199-2205.
35. HILL, C.L., BIENIASZ, P.D., and McCLURE, M.O. (1999). Properties of human foamy virus relevant to its development as a vector for gene therapy. J. Gen. Virol. 80, 2003-2009.
36. HOOK, K.E., NELSON, J.M., ROBERTS, B.J., GRISWOLD, D.P., and LEOPOLD, W.R. (1986). Cell cycle effects of trimetrexate (CI898). Cancer Chemother. Pharmacol. 16, 116-120.
37. HOOKS, J.J., and GIBBS, C.J., JR. (1975). The foamy viruses [review]. Bacteriol. Rev. 39, 169-185.
38. HORN, P.A., MORRIS, J.C., BUKOVSKY, A.A., ANDREWS, R.G., NALDINI, L., KURRE, P., and KIEM, H.-P. (2002a). Lentivirus-mediated gene transfer into hematopoietic repopulating cells in baboons. Gene Ther. 9, 1464-1471.
39. HORN, P.A., TOPP, M.S., MORRIS, J.C., RIDDELL, S.R., and KIEM, H.-P. (2002b). Highly efficient gene transfer into baboon marrow repopulating cells using GALV-pseudotype oncoretroviral vectors produced by human packaging cells. Blood 100, 3960-3967.
40. HORN, P.A., THOMASSON, B.M., WOOD, B.L., ANDREWS, R.G., MORRIS, J.C., and KIEM, H.-P. (2003). Distinct hematopoietic stem/progenitor cell populations are responsible for repopulating NOD/SC1D mice compared with nonhuman primates. Blood 102, 4329-4335.
41. HORN, P.A., KEYSER, K.A., PETERSON, L.J., NEFF, T., THOMASSON, B.M., THOMPSON, J., and KIEM, H.-P. (2004). Efficient lentiviral gene transfer to canine repopulating cells using an overnight transduction protocol. Blood 103, 3710-3716.
42. JIN, L., ZENG, H., CHIEN, S., OTTO, K.G., RICHARD, R.E., EMERY, D.W., and BLAU, C.A. (2000). In vivo selection using a cell-growth switch. Nat. Genet. 26, 64-66.
43. JOSEPHSON, N.C., VASSILOPOULOS, G. , TROBRIDGE, G.D., PRIESTLY, G.V., WOOD, B.L., PAPAYANNOPOULOU, T., and RUSSELL, D.W. (2002). Transduction of human NOD/SCID-repopulating cells with both lymphoid and myeloid potential by foamy virus vectors. Proc. Natl. Acad. SCi. U.S.A. 99, 8295-8300.
44. JOSEPHSON, N.C., TROBRIDGE, G., and RUSSELL, D.W. (2004). Transduction of long-term and mobilized peripheral blood-derived NOD/SCID repopulating cells by foamy virus vectors. Hum. Gene Ther. 15, 87-92.
45. KAVANAUGH, M.P., MILLER, D.G., ZHANG, W., LAW, W., KOZAK, S.L., KABAT, D., and MILLER, A.D. (1994). Cell-surface receptors for gibbon ape leukemia virus and amphotropic murine retrovirus are inducible sodium-dependent phosphate symporters. Proc. Natl. Acad. SCi. U.S.A. 91, 7071-7075.
46. KELLY, P.F., VANDERGRIFF, J., NATHWANI, A., NIENHUIS, A.W., and VANIN, E.F. (2000). Highly efficient gene transfer into cord blood nonobese diabetic/severe combined immunodeficiency repopulating cells by oncoretroviral vector particles pseudotyped with the feline endogenous retrovirus (RD114) envelope protein. Blood 96, 1206-1214.
47. KELLY, P.F., CARRINGTON, J., NATHWANI, A., and VANIN, E.F. (2001). RD114-pseudotyped oncoretroviral vectors: Biological and physical properties. Ann. N.Y. Acad. Sci. 938, 262-276; discussion, 276-277.
48. KELLY, P.F., DONAHUE, R.E., VADERGRIFF, J.A., TAKATOKU, M., BONIFACINO, A.C., AGRICOLA, B.A., METZGER, M.E., DUNBAR, C.E., NIENHUIS, A.W., and VANIN, E.F. (2003). Prolonged multilineage clonal hematopoiesis in a rhesus recipient of CD34 positive cells marked with a RD114 pseudotyped oncoretroviral vector. Blood Cells Mol. Dis. 30, 132-143.
49. KIEM, H.-P., DAROVSKY, B., VON KALLE, C., GOEHLE, S., GRAHAM, T., MILLER, A.D., STORE, R., and SCHUENING, F.G. (1996). Long-term persistence of canine hematopoietic cells genetically marked by retrovirus vectors. Hum. Gene Ther. 7, 89-96.
50. KIEM, H.-P., HEYWARD, S., WINKLER, A., POTTER, J., ALLEN, J.M., MILLER, A.D., and ANDREWS, R.G. (1997). Gene transfer into marrow repopulating cells: Comparison between amphotropic and gibbon ape leukemia virus pseudotyped retroviral vectors in a competitive repopulation assay in baboons. Blood 90, 4638-4645.
51. KIEM, H.-P., ANDREWS, R.G., MORRIS, J., PETERSON, L., HEYWARD, S., ALLEN, J.M., RASKO, J.E.J., POTTER, J., and MILLER, A.D. (1998). Improved gene transfer into baboon marrow repopulating cells using recombinant human fibronectin fragment CH-296 in combination with interleukin-6, stem cell factor, FLT-3 ligand, and megakaryocyte growth and development factor. Blood 92, 1878-1886.
52. KIEM, H.-P., McSWEENEY, P.A., BRUNO, B., GOERNER, M., BURON, G., MORRIS, J., STORB, R., and MILLER, A.D. (1999). Improved gene transfer into canine hematopoietic repopulating cells using CD34-enriched marrow cells in combination with a gibbon ape leukemia virus-pseudotype retroviral vector. Gene Ther. 6, 966-972.
53. KIEM, H.-P., RASKO, J.E.J., MORRIS, J., PETERSON, L., KURRE, P., and ANDREWS, R.G. (2002). Ex vivo selection for oncoretrovirally transduced green fluorescent protein-expressing CD34-enriched cells increases short-term engraftment of transduced cells in baboons. Hum. Gene Ther. 13, 891-899.
54. KIEM, H.-P., SELLERS, S., THOMASSON, B., MORRIS, J.C., TISDALE, J.F., HORN, P.A., HEMATTI, P., ADLER, R., KURAMOTO, K., CALMELS, B., BONIFACINO, A., HU, J., VON KALLE, C., SCHMIDT, M., SORRENTINO, B., NIENHUIS, A., BLAU, C.A., ANDREWS, R.G., DONAHUE, R.E., and DUNBAR, C.E. (2004). Long-term clinical and molecular follow-up of large animals receiving retrovirally transduced stem and progenitor cells: No progression to clonal hematopoiesis or leukemia. Mol. Ther. 9, 389-395.
55. KLUG, C.A., CHESHIER, S., and WEISSMAN, I.L. (2000). Inactivation of a GFP retrovirus occurs at multiple levels in long-term repopulating stem cells and their differentiated progeny. Blood 96, 894-901.
56. KOHN, D.B., WEINBERG, K.I., NOLTA, J.A., HEISS, L.N., LENARSKY, C., CROOKS, G.M., HANLEY, M.E., ANNETT, G., BROOKS, J.S., EL-KHOUREIY, A., LAWRENCE, K., WELLS, S., MOEN, R.C., BASTIAN, J., WILLIAMS-HERMAN, D.E., ELDER, M., WARA, D., BOWEN, T., HERSHFIELD, M.S., MULLEN, C.A., BLAESE, R.M., and PARKMAN, R. (1995). Engraftment of gene-modified umbilical cord blood cells in neonates with adenosine deaminase deficiency. Nat. Med. 1, 1017-1023.
57. KROSL, J., AUSTIN, P., BESLU, N., KROON, E., HUMPHRIES, R.K., and SAUVAGEAU, G. (2003). In vitro expansion of hematopoietic stem cells by recombinant TAT-HOXB4 protein. Nat. Med. 9, 1428-1432.
58. KUME, A., KOREMOTO, M., XU, R., OKADA, T., MIZUKAMI, H., HANAZONO, Y., HASEGAWA, M., and OZAWA, K. (2003). In vivo expansion of transduced murine hematopoietic cells with a selective amplifier gene. J. Gene Med. 5, 175-181.
59. KURRE, P., KIEM, H.-P., MORRIS, J., HEYWARD, S., BATTINI, J.-L., and MILLER, A.D. (1999). Efficient transduction by an amphotropic retrovirus vector is dependent on high-level expression of the cell surface virus receptor. J. Virol. 73, 495-500.
60. KURRE, P., MORRIS, J., HORN, P.A., HARKEY, M.A., ANDREWS, R.G., and KIEM, H.-P. (2001a). Gene transfer into baboon repopulating cells: A comparison of flt-3 ligand and megakaryocyte growth and development factor versus IL-3 during ex vivo transduction. Mol. Ther. 3, 920-927.
61. + cells emphasize limited transduction at low receptor levels. Gene Ther. 8, 593-599.
62. KURRE, P., MORRIS, J., ANDREWS, R.G., KOHN, D.B., and KIEM, H.-P. (2002). Kinetics of fluorescence expression in nonhuman primates transplanted with GFP retrovirus-modified CD34 cells. Mol. Ther. 6, 83-90.
63. LADIGES, W.C., STORB, R., and THOMAS, E.D. (1990). Canine models of bone marrow transplantation. Lab. Anim. Sci. 40, 11-15.
64. LAND, H., PARADA, L.F., and WEINBERG, R.A. (1983). Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature 304, 596-602.
65. LAROCHELLE, A., VORMOOR, J., HANENBERG, H., WANG, J.C., BHATIA, M., LAPIDOT, T., MORITZ, T., MURDOCH, B., XIAO, X.L., KATO, I., WILLIAMS, D.A., and DICK, J.E. (1996). Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: Implications for gene therapy. Nat. Med. 2, 1329-1337.
66. LE DOUX, J.M., MORGAN, J.R., SNOW, R.G., and YARMUSH, M.L. (1996). Proteoglycans secreted by packaging cell lines inhibit retrovirus infection. J. Virol. 70, 6468-6473.
67. LEMISCHKA, I.R., RAULET, D.H., and MULLIGAN, R.C. (1986). Developmental potential and dynamic behavior of hematopoietic stem cells. Cell 45, 917-927.
68. LEWIS, P.F., and EMERMAN, M. (1994). Passage through mitosis is required for oncoretroviruses but not for the human immunodeficiency virus. J. Virol. 68, 510-516.
69. LICHT, T., HASKINS, M., HENTHORN, P., KLEIMAN, S.E., BODINE, D.M., WHITWAM, T., PUCK, J.M., GOTTESMAN, M.M., and MELNICZEK, J.R. (2002). Drug selection with paclitaxel restores expression of linked IL-2 receptor γ-chain and multidrug resistance (MDR1) transgenes in canine bone marrow. Proc. Natl. Acad. Sci. U.S.A. 99, 3123-3128.
70. MARIS, M., and STORB, R. (2002). Outpatient allografting in hematologic malignancies and nonmalignant disorders-applying lessons learned in the canine model to humans. In: Bashey, A., and Ball, E.D., eds. Non-Myeloablative Allogeneic Transplantation. (Kluwer Academic, Boston, MA) p. 149.
71. MILLER, D.G., ADAM, M.A., and MILLER, A.D. (1990). Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol. Cell. Biol. 10, 4239-4242.
72. + cells that mediate long-term engraftment of NOD/SCID mice by HIV vectors. Science 283, 682-686.
73. NALDINI, L., BLOMER, U., GAGE, F.H., TRONO, D., and VERMA, I.M. (1996a). Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc. Natl. Acad. Sci. U.S.A. 93, 11382-11388.
74. NALDINI, L., BLÖMER, U., GALLAY, P., ORY, D., MULLIGAN, R., GAGE, F.H., VERMA, I.M., and TRONO, D. (1996b). In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272, 263-267.
75. NEFF, T., HORN, P.A., VALLI, V.E., GOWN, A.M., WARDWELL, S., WOOD, B.L., VON KALLE, C., SCHMIDT, M., PETERSON, L.J., MORRIS, J.C., RICHARD, R.E., CLACKSON, T., KIEM, H.-P., and BLAU, C.A. (2002). Pharmacologically regulated in vivo selection in a large animal. Blood 100, 2026-2031.
76. NEFF, T., HORN, P.A., PETERSON, L.J., THOMASSON, B.M., THOMPSON, J., WILLIAMS, D.A., SCHMIDT, M., GEORGES, G.E., VON KALLE, C., and KIEM, H.-P. (2003). Methylguanine methyltransferase-mediated in vivo selection and chemoprotection of allogeneic stem cells in a large animal model. J. Clin. Invest. 112, 1581-1588.
77. NEFF, T., PETERSON, L.J., MORRIS, J.C., THOMPSON, J., ZHANG, X., HORN, P.A., THOMASSON, B.M., and KIEM, H.-P. (2004). Efficient gene transfer to hematopoietic repopulating cells using concentrated RD114-pseudotype vectors produced by human packaging cells [letter to the editor]. Mol. Ther. 9, 157-159.
78. NEFF, T., BEARD, B.C., PETERSON, L.J., ANANDAKUMAR, P., THOMPSON, J., and KIEM, H.-P. (2005). Polyclonal chemoprotection against temozolomide in a large animal model of drug resistance gene therapy. Blood 105, 997-1002.
79. NYBERG, K., CARTER, B.J., CHEN, T., DUNBAR, C., FLOTTE, T.R., ROSE, S., ROSENBLUM, D., SIMEK, S.L., and WILSON, C. (2004). Workshop on long-term follow-up of participants in human gene transfer research. Mol. Ther. 10, 976-980.
80. OCHMAN, H., GERBER, A.S., and HARTL, D.L. (1988). Genetic applications of an inverse polymerase chain reaction. Genetics 120, 621-623.
81. ORLIC, D., GIRARD, L.J., JORDAN, C.T., ANDERSON, S.M., CLINE, A.P., and BODINE, D.M. (1996). The level of mRNA encoding the amphotropic retrovirus receptor in mouse and human hematopoetic stem cells is low and correlates with the efficiency of retrovirus transduction. Proc. Natl. Acad. Sci. U.S.A. 93, 11097-11102.
82. PERSONS, D.A., ALLAY, E.R., SABATINO, D.E., KELLY, P., BODINE, D.M., and NIENHUIS, A.W. (2001). Functional requirements for phenotypic correction of murine β-thalassemia: Implications for human gene therapy. Blood 97, 3275-3282.
83. PERSONS, D.A., ALLAY, D.A., BONIFACINO, A., LU, T., AGRICOLA, B., METZGER, M.E., DONAHUE, R.E., DUNBAR, C.E., and SORRENTINO, B.P. (2004). Transient in vivo selection of transduced peripheral blood cells using antifolate drug selection in rhesus macaques that received transplants with hematopoietic stem cells expressing dihydrofolate reductase vectors. Blood 103, 796-803.
84. PIETSCHMANN, T., HEINKELEIN, M., HELDMANN, M., ZENTGRAF. H., RETHWILM, A., and LINDEMANN, D. (1999). Foamy virus capsids require the cognate envelope protein for particle export. J. Virol. 73, 2613-2621.
85. PORTER, C.D., COLLINS, M.K., TAILOR, C.S., PARKAR, M.H., COSSET, F.L., WEISS, R.A., and TAKEUCHI, Y. (1996). Comparison of efficiency of infection of human gene therapy target cells via four different retroviral receptors. Hum. Gene Ther. 7, 913-919.
86. REISER, J., HARMISON, G., KLUEPFEL-STAHL, S., BRADY, R.O., KARLSSON. S., and SCHUBERT, M. (1996). Transduction of non-dividing cells using pseudotyped defective high-titer HIV type 1 particles. Proc. Natl. Acad. Sci. U.S.A. 93, 15266-15271.
87. RICHARD, R.E., WEINREICH, M., CHANG, K.H., IEREMIA, J., STEVENSON, M.M., and BLAU, C.A. (2004). Modulating erythrocyte chimerism in a mouse model of pyruvate kinase deficiency. Blood 103, 4432-4439.
88. ROBBINS, P.B., SKELTON, D.C., YU, X.J., HALENE, S., LEONARD, E.H., and KOHN, D.B. (1998). Consistent, persistent expression from modified retroviral vectors in murine hematopoieitic stem cells. Proc. Natl. Acad. Sci. U.S.A. 95, 10182-10187.
89. ROSENZWEIG, M., MACVITTIE, T.J., HARPER, D., HEMPEL, D., GLICKMAN, R.L., JOHNSON, R.P., FARESE, A.M., WHITING-THEOBALD, N., LINTON, G.F., YAMASAKI, G., JORDAN, C.T., and MALECH, H.L. (1999). Efficient and durable gene marking of hematopoietic progenitor cells in nonhuman primates after nonablative conditioning. Blood 94, 2271-2286.
90. RUSSELL, D.W., and MILLER, A.D. (1996). Foamy virus vectors. J. Virol. 70, 217-222.
91. SABATINO, D.E., DO, B.K.Q., PYLE, L.C., SEIDEL, N.E., GIRARD, L.J., SPRATT, S.K., ORLIC, D., and BODINE, D.M. (1997). Amphotropic or gibbon ape leukemia virus (GALV) retrovirus binding and transduction correlates with the level of receptor mRNA in human hematopoietic cell lines. Blood Cells Mol. Dis. 23, 422-433.
92. + cells derived from human and non-human primates. Blood 100, 823-832.
93. SAUVAGEAU, G., BERGIN, M.E., EAVES, C.J., LAWRENCE, H.J., LARGMAN, C., LANSDORP, P.M., and HUMPHRIES, R.K. (1995). Overexpression of HOXB4 in hematopoietic cells causes the selective expansion of more primitive populations in vitro and in vivo. Genes Dev. 9, 1753-1765.
94. + cells, but impairs lymphomyeloid differentiation. Blood 101, 1759-1768.
95. SCHMIDT, M., HOFFMANN, G., WISSLER, M., LEMKE, N., MUSSIG, A., GLIMM, H.. WILLIAMS, D.A., RAGG, S., HESEMANN, C.U., and VON KALLE, C. (2001). Detection and direct genomic sequencing of multiple rare unknown flanking DNA in highly complex samples. Hum. Gene Ther. 12, 743-749.
96. SCHRODER, A.R., SHINN, P., CHEN, H., BERRY, C., ECKER, J.R., and BUSHMAN. F. (2002). HIV-1 integration in the human genome favors active genes and local hotspots. Cell 110, 521-529.
97. SHI, P.A., DE ANGIOLETTI, M., DONAHUE, R.E., NOTARO, R., LUZZATTO, L., and DUNBAR, C.E. (2004). In vivo gene marking of rhesus macaque long-term repopulating hematopoietic cells using a VSV-G pseudotyped versus amphotropic oncoretroviral vector. J. Gene Med. 6, 367-373.
98. SONG, B., JAVANBAKHT, H., PERRON, M., PARK, D.H., STREMLAU, M., and SODROSKI. J. (2005). Retrovirus restriction by TRIMSα variants from Old World and New World primates. J. Virol. 79, 3930-3937.
99. SORRENTINO, B.P. (2004). Clinical strategies for expansion of haematopoietic stem cells [review]. Nat. Rev. Immunol. 4, 878-888.
100. STREMLAU, M., OWENS, C.M., PERRON, M.J., KIESSLING, M., AUTISSIER, P., and SODROSKI, J. (2004). The cytoplasmic body component TRIMSα restricts HIV-1 infection in Old World monkeys. Nature 427, 848-853.
101. STREMLAU, M., PERRON, M., WELIKALA, S., and SODROSKI, J. (2005). Species-specific variation in the B30.2(SPRY) domain of TRIMSα determines the potency of human immunodeficiency virus restriction. J. Virol. 79, 3139-3145.
102. TISDALE, J.F., HANAZONO, Y., SELLERS, S.E., AGRICOLA, B.A., METZGER, M.E., DONAHUE, R.E., and DUNBAR, C.E. (1998). Ex vivo expansion of genetically marked rhesus peripheral blood progenitor cells results in diminished long-term repopulating ability. Blood 92, 1131-1141.
103. TROBRIDGE, G., and RUSSELL. D.W. (2004). Cell cycle requirements for transduction by foamy virus vectors compared to those of oncovirus and lentivirus vectors. J. Virol. 78, 2327-2335.
104. TROBRIDGE, G., VASSILOPOULOS, G., JOSEPHSON, N., and RUSSELL, D.W. (2002). Gene transfer with foamy virus vectors. Methods Enzymol. 346, 628-648.
105. + cells [abstract 386]. Mol. Ther. 11(Suppl. 1), S149.
106. UEDA, K., HANAZONO, Y., SHIBATA, H., AGEYAMA, N., UEDA, Y., OGATA, S., TABATA, T., NAGASHIMA, T., TAKATOKU, M., KUME, A., IKEHARA, S. , TANIWAKI, M., TERAO, K., HASEGAWA, M., and OZAWA, K. (2004). High-level in vivo gene marking after gene-modified autologous hematopoietic stem cell transplantation without marrow conditioning in nonhuman primates. Mol. Ther. 10, 469-477.
107. VAN BEUSECHEM, V.W., KUKLER, A., HEIDT, P.J., and VALERIO, D. (1992). Long-term expression of human adenosine deaminase in rhesus monkeys transplanted with retrovirus-infected bone-marrow cells. Proc. Natl. Acad. Sci. U.S.A. 89, 7640-7644.
108. VASSILOPOULOS, G., TROBRIDGE, G., JOSEPHSON, N.C., and RUSSELL, D.W. (2001). Gene transfer into murine hematopoietic stem cells with helper-free foamy virus vectors. Blood 98, 604-609.
109. VON KALLE, C., KIEM, H.-P., GOEHLE, S., DAROVSKY, B., HEIMFELD, S., TOROK-STORB, B., STORE, R., and SCHUENING, F.G. (1994). Increased gene transfer into human hematopoietic progenitor cells by extended in vitro exposure to a pseudotyped retroviral vector. Blood 84, 2890-2897.
110. WILLIAMS, D.A., LEMISCHKA, I.R., NATHAN, D.G., and MULLIGAN, R.C. (1984). Introduction of new genetic material into pluripotent haematopoietic stem cells of the mouse. Nature 310, 476-480.
111. WILSON, C., REITZ, M.S., OKAYAMA, H., and EIDEN, M.V. (1989). Formation of infectious hybrid virions with gibbon ape leukemia virus and human T-cell leukemia virus retroviral envelope glycoproteins and the Gag and Pol proteins of Moloney murine leukemia virus. J. Virol. 63, 2374-2378.
112. + progenitors using clinically feasible methods. Mol. Ther. 1, 285-293.
113. WU, X., LI, Y., CRISE, B., and BURGESS, S.M. (2003). Transcription start regions in the human genome are favored targets for MLV integration. Science 300, 1749-1751.
114. XU, L.C., YOUNG, H.A., BLANCO, M., KESSLER, S., ROBERTS, A.B., and KARLSSON, S. (1994). Poor transduction efficiency of human hematopoietic progenitor cells by a high-liter amphotropic retrovirus producer cell clone. J. Virol. 68, 7634-7636.
115. 6-benzylguanine. Cancer Res. 58, 1936-1945.
116. YANG, Y., VANIN, E.F., WHITT, M.A., FORNEROD, M., ZWART, R., SCHNEIDERMAN, R.D., GROSVELD, G., and NIENHUIS, A.W. (1995). Inducible, high-level production of infectious murine leukemia retroviral vector particles pseudotyped with vesicular stomatitis virus G envelope protein. Hum. Gene Ther. 6, 1203-1213.
117. YEE, J.K., MIYANOHARA, A., LAPORTE, P., BOUIC, K., BURNS, J.C., and FRIEDMANN, T. (1994). A general method for the generation of high-titer, pantropic retroviral vectors: Highly efficient infection of primary hepatocytes. Proc. Natl. Acad. Sci. U.S.A. 91, 9564-9568.
118. ZHANG, X.-B., PETERSON, L., KNAPP, A.A., BEARD, B.C., HUMPHRIES, R.K., and KIEM, H.-P. (2005). HOXB4 overexpression expands short-term repopulating cells in nonhuman primates and dogs [abstract 456]. Mol. Ther. 11(Suppl. 1), S177.